A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases

Figure 2

Meta-analysis estimating the correlation between CCAT2 and clinicopathological parameters in cancer patients: (a) Age (, fixed effects model); (b) gender (, fixed effects model); (c) tumor size (, random effects model); (d) clinical stage (, fixed effects model); (e) T (, fixed effects model); (f) N (, random effects model); (g) M (, fixed effects model); (h) differentiation (, random effects model).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)